Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Reiser

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
Kidney International Reports|January 10, 2022
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 IntegrinMichelle A Hladunewich, Dan Cattran, Sanjeev M Sethi, et al.
Annals of Translational Medicine|July 5, 2023
Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factorsPriyanka Rashmi, Tara K Sigdel, Dmitry Rychkov, et al.
Transplantation|September 16, 2015
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin ActivationOliver Staeck, Torsten Slowinski, Ina Lieker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2018
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney diseaseLi Lv, Fang Wang, Liang Wu, et al.
Plos One|March 9, 2010
Novel siRNA delivery system to target podocytes in vivoPeter V Hauser, Jeffrey W Pippin, Cora Kaiser, et al.
Lipids in Health and Disease|November 5, 2011
Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese miceMehmet M Altintas, Maria A Rossetti, Behzad Nayer, et al.
Transplantation|December 1, 2017
Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney TransplantationSami Alasfar, Dany Matar, Robert A Montgomery, et al.
Kidney International Reports|November 29, 2023
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKDClaudia Sommerer, Sandra Müller-Krebs, Jennifer Nadal, et al.
BMC Nephrology|July 23, 2015
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial groupHoward Trachtman, Suzanne Vento, Emily Herreshoff, et al.
Ebiomedicine|November 4, 2025
Soluble urokinase receptor is a kidney-specific vasoconstrictorSebastian Buhl Rasmussen, Rasmus Bo Lindhardt, Georgina Gyarmati, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
Kidney International Reports|January 10, 2022
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 IntegrinMichelle A Hladunewich, Dan Cattran, Sanjeev M Sethi, et al.
Annals of Translational Medicine|July 5, 2023
Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factorsPriyanka Rashmi, Tara K Sigdel, Dmitry Rychkov, et al.
Transplantation|September 16, 2015
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin ActivationOliver Staeck, Torsten Slowinski, Ina Lieker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2018
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney diseaseLi Lv, Fang Wang, Liang Wu, et al.
Plos One|March 9, 2010
Novel siRNA delivery system to target podocytes in vivoPeter V Hauser, Jeffrey W Pippin, Cora Kaiser, et al.
Lipids in Health and Disease|November 5, 2011
Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese miceMehmet M Altintas, Maria A Rossetti, Behzad Nayer, et al.
Transplantation|December 1, 2017
Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney TransplantationSami Alasfar, Dany Matar, Robert A Montgomery, et al.
Kidney International Reports|November 29, 2023
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKDClaudia Sommerer, Sandra Müller-Krebs, Jennifer Nadal, et al.
BMC Nephrology|July 23, 2015
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial groupHoward Trachtman, Suzanne Vento, Emily Herreshoff, et al.
Ebiomedicine|November 4, 2025
Soluble urokinase receptor is a kidney-specific vasoconstrictorSebastian Buhl Rasmussen, Rasmus Bo Lindhardt, Georgina Gyarmati, et al.
Pageof 25